Description

Ipamorelin Nasal Spray

Ipamorelin
CAS number	170851-70-4
Molar Mass	711.868 g·mol−1
Chemical Formula	C38H49N9O5
IUPAC Name	(2S)-6-Amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide

Introduction

Ipamorelin is a peptide known for its research applications in the field of endocrinology and metabolism. As a growth hormone secretagogue, it has garnered attention for its potential impact on various physiological processes. It is essential to note that Ipamorelin Vials are strictly intended for research purposes and are not for human consumption.

Key Characteristics

Ipamorelin Nasal Sprays contain the synthetic peptide Ipamorelin, a growth hormone-releasing hexapeptide. This peptide stimulates the release of growth hormone without affecting cortisol levels, making it a unique and valuable tool for research endeavors.

Research Applications

Researchers utilize Ipamorelin Nasal Sprays to investigate the intricate mechanisms involved in growth hormone regulation, metabolism, and related pathways. The controlled and precise nature of Ipamorelin’s action makes it an invaluable asset in various experimental settings.

Research Benefits

Ipamorelin and Weight Gain

Studies suggest that Ipamorelin may play a role in regulating body weight by promoting the release of growth hormone, which in turn may influence metabolism. Researchers are exploring its potential implications for understanding and addressing weight gain and related metabolic processes.

Ipamorelin and Bone Health

Research indicates that Ipamorelin may have positive effects on bone health by stimulating the release of growth hormone, which is crucial for bone growth and density. Investigations in this area aim to shed light on the potential applications of Ipamorelin in promoting bone health.

Ipamorelin and Glucocorticoids

In research settings, Ipamorelin is being studied for its interactions with glucocorticoids, a class of steroid hormones involved in various physiological processes. Exploring the interplay between Ipamorelin and glucocorticoids provides valuable insights into endocrine regulation and related health implications.

Summary

Ipamorelin Nasal Sprays offer a controlled and targeted approach to studying growth hormone regulation and its impact on various physiological processes. The peptide’s unique characteristics make it a valuable tool in research applications focused on weight gain, bone health, and interactions with glucocorticoids. It is imperative to emphasize that Ipamorelin Vials are intended strictly for research purposes and are not suitable for human consumption.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Lall S, Tung LY, Ohlsson C, Jansson JO, Dickson SL. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem Biophys Res Commun. 2001 Jan 12;280(1):132-8. doi: 10.1006/bbrc.2000.4065. PMID: 11162489. [Read More]
2. Svensson J, Lall S, Dickson SL, Bengtsson BA, Rømer J, Ahnfelt-Rønne I, Ohlsson C, Jansson JO. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. J Endocrinol. 2000 Jun;165(3):569-77. doi: 10.1677/joe.0.1650569. PMID: 10828840. [Read More]
3. Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Horm IGF Res. 1999 Apr;9(2):106-13. doi: 10.1054/ghir.1999.9998. PMID: 10373343. [Read More]